SIG
GSK icon

Stonegate Investment Group’s GSK GSK Stock Holding History

Stonegate Investment Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-6,573
Closed -$234K – 339
2023
Q2 		$234K Sell
6,573
-4,645
-41% -$167K 0.01% 281
2023
Q1 		$399K Buy
11,218
+497
+5% +$17.4K 0.02% 226
2022
Q4 		$377K Sell
10,721
-2,525
-19% -$84.1K 0.02% 226
2022
Q3 		$390K Buy
13,246
+2,718
+26% +$103K 0.02% 204
2022
Q2 		$573K Buy
10,528
+1,727
+20% +$95.3K 0.03% 180
2022
Q1 		$479K Sell
8,801
-80
-0.9% -$4.34K 0.02% 176
2021
Q4 		$490K Buy
+8,881
New +$462K 0.02% 177

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Stonegate Investment Group's GSK Position: Q3 2023 in Review

Stonegate Investment Group sold out of GSK (GSK) in Q3 2023, closing a stake of 6,573 shares — an estimated $234K sold.

Stonegate Investment Group first reported a position in GSK in Q4 2021 and held it in 7 quarters. The position peaked at $573K in Q2 2022. 846 funds tracked by Wall St. Rank hold GSK as of Q3 2023.

  • Stonegate Investment Group reported no remaining GSK position as of Q3 2023 after selling out during the quarter.
  • Stonegate Investment Group sold 6,573 GSK shares in Q3 2023, an estimated $234K.
  • Stonegate Investment Group first reported a position in GSK in Q4 2021 and held it in 7 quarters.
  • Stonegate Investment Group's GSK position peaked at $573K in Q2 2022.
  • 846 funds tracked by Wall St. Rank held GSK as of Q3 2023.

Based on Stonegate Investment Group's 13F filing for Q3 2023, filed 24 Oct 2023.